TRIMTECH Therapeutics
Develops small molecule therapies to degrade protein aggregates in neurodegenerative diseases
$47MSeed+
Role not disclosedMH
MP Healthcare Venture Management
Activity from announced rounds
Activity in this selectionchicago-trading-company-ventures-863b6bce
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $47M 1 disclosed · full round size, not this investor’s share